« Back
Home /
DCC-3014

DCC-3014

Manufacturer	TargetMol
Category	Reagents & Chemicals Molecules
Type	Molecules
Specific against	other
Amount	500mg
Item no.	TMO-T10652-500mg
Targets	KIT
CASRN	1628606-05-2
eClass 6.1	32169090
eClass 9.0	32169090
Available
Alias	1628606-05-2, DCC-3014
Short Description	Vimseltinib (DCC-3014) is a c-FMS (CSF-IR) and c-Kit dual inhibitor (IC50s: <0.01 μM and 0.1-1 μM) extracted from the patent WO2014145025A2 (Example 10).
Shipping	cool pack
Storage	-20°
Target names or alias	DCC-3014
Molecular Weight	431, 49
Pathway	Tyrosine Kinase/Adaptors
Target	CSF-1R\|\|\|c-Fms\|\|\|c-Kit

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

TMO-T10652-500mg-datasheet.pdf

TMO-T10652-500mg-safety-datasheet.pdf